State Board of Administration of Florida Retirement System’s Aegerion Pharmaceuticals AEGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-28,174
Closed -$104K 2418
2016
Q1
$104K Hold
28,174
﹤0.01% 2333
2015
Q4
$285K Hold
28,174
﹤0.01% 2130
2015
Q3
$383K Buy
28,174
+140
+0.5% +$2.49K ﹤0.01% 1983
2015
Q2
$532K Buy
28,034
+677
+2% +$14.7K ﹤0.01% 1919
2015
Q1
$716K Sell
27,357
-872
-3% -$22.2K ﹤0.01% 1756
2014
Q4
$591K Sell
28,229
-689
-2% -$17.4K ﹤0.01% 1885
2014
Q3
$965K Sell
28,918
-1,520
-5% -$47.2K ﹤0.01% 1581
2014
Q2
$977K Buy
30,438
+2,551
+9% +$95K ﹤0.01% 1644
2014
Q1
$1.29M Sell
27,887
-1,124
-4% -$65.9K ﹤0.01% 1391
2013
Q4
$2.06M Sell
29,011
-693
-2% -$53K 0.01% 1129
2013
Q3
$2.55M Sell
29,704
-8,781
-23% -$744K 0.01% 1021
2013
Q2
$2.44M Buy
+38,485
New +$2.04M 0.01% 1020

Other funds holding AEGR

State Board of Administration of Florida Retirement System's AEGR Position: Q2 2016 in Review

State Board of Administration of Florida Retirement System sold out of Aegerion Pharmaceuticals (AEGR) in Q2 2016, closing a stake of 28,174 shares — an estimated $104K sold.

State Board of Administration of Florida Retirement System first reported a position in AEGR in Q2 2013 and held it in 12 quarters. The position peaked at $2.55M in Q3 2013. 71 funds tracked by Wall St. Rank hold AEGR as of Q2 2016.

  • State Board of Administration of Florida Retirement System reported no remaining Aegerion Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 28,174 Aegerion Pharmaceuticals shares in Q2 2016, an estimated $104K.
  • State Board of Administration of Florida Retirement System first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 12 quarters.
  • State Board of Administration of Florida Retirement System's Aegerion Pharmaceuticals position peaked at $2.55M in Q3 2013.
  • 71 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q2 2016.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2016, filed 4 Aug 2016.